TY - JOUR AU - Wang, Feifei AU - Wang, Ruliang AU - Li, Qiuwen AU - Qu, Xueling AU - Hao, Yixin AU - Yang, Jingwen AU - Zhao, Huixia AU - Wang, Qian AU - Li, Guanghui AU - Zhang, Fengyun AU - Zhang, He AU - Zhou, Xuan AU - Peng, Xioumei AU - Bian, Yang AU - Xiao, Wenhua PY - 2017 DA - 2017/01/13 TI - A transcriptome profile in hepatocellular carcinomas based on integrated analysis of microarray studies JO - Diagnostic Pathology SP - 4 VL - 12 IS - 1 AB - Despite new treatment options for hepatocellular carcinomas (HCC) recently, 5-year survival remains poor, ranging from 50 to 70%, which may attribute to the lack of early diagnostic biomarkers. Thus, developing new biomarkers for early diagnosis of HCC, is extremely urgent, aiming to decrease HCC-related deaths. SN - 1746-1596 UR - https://doi.org/10.1186/s13000-016-0596-x DO - 10.1186/s13000-016-0596-x ID - Wang2017 ER -